Mt-Act
MT-act is a CNRS spin-off.#techtransfer We develop class compounds to treat human pathologies that share a common molecular defect; dysfunction of the skeleton of the cells called microtubules - abbreviated MT. Stiffening of the skeleton of our cells is a central disease driver. That is why we act on them. We developed a technology platform to charter an entirely neglected pharmaceutical space. MT-act prioritizes indications based on scientific evidence, proven unmet medical needs and where the roadmap to patients is feasible and desired.
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 8 verified contacts at Mt-Act
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Mt-Act
7 distinct titles indexed · top 7 shown.
- 1ceo cso - growth focussed driving value
- 1coo
- 1doctorant en thèse cifre de chimie thérapeutique
- 1laboratory technician
- 1mt-act
- 1project manager research and development
- 1research & development project manager (biotechnology)
Sign up to unlock all 8 contacts at Mt-Act
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Mt-Act
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.